NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
| Country | United States |
|---|---|
| Deadline | 2027-02-03 (73 days left) |
| Published | 2024-12-05 |
| Sectors | Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-25-026. CFDA: 93.840, 93.838, 93.233, 93.837, 93.839
The buyer, the value, the full description and the link to the official notice are available with a free account.